Logo image of NUV

NUVEEN MUNICIPAL VALUE (NUV) Stock Price, Quote, News and Overview

NYSE:NUV - New York Stock Exchange, Inc. - US6709281009 - Currency: USD

8.67  -0.01 (-0.12%)

Fundamental Rating

2

NUV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. NUV has a bad profitability rating. Also its financial health evaluation is rather negative. NUV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year NUV was profitable.
NUV had positive earnings in 4 of the past 5 years.
NUV had a negative operating cash flow in each of the past 5 years.
NUV Yearly Net Income VS EBIT VS OCF VS FCFNUV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M -300M

1.2 Ratios

The last Return On Invested Capital (3.12%) for NUV is above the 3 year average (2.88%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3%
ROE 3.04%
ROIC 3.12%
ROA(3y)-3.15%
ROA(5y)-0.67%
ROE(3y)-3.2%
ROE(5y)-0.67%
ROIC(3y)2.88%
ROIC(5y)2.83%
NUV Yearly ROA, ROE, ROICNUV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5 -10 -15

1.3 Margins

NUV's Profit Margin has declined in the last couple of years.
NUV's Operating Margin has been stable in the last couple of years.
NUV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 87.61%
PM (TTM) 66.8%
GM 98.86%
OM growth 3Y0.06%
OM growth 5Y0.04%
PM growth 3Y-0.35%
PM growth 5Y-5.23%
GM growth 3Y-0.16%
GM growth 5Y-0.02%
NUV Yearly Profit, Operating, Gross MarginsNUV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200 -300 -400

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, NUV has about the same amount of shares outstanding.
NUV has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NUV is higher compared to a year ago.
NUV Yearly Shares OutstandingNUV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
NUV Yearly Total Debt VS Total AssetsNUV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

NUV has an Altman-Z score of 37.78. This indicates that NUV is financially healthy and has little risk of bankruptcy at the moment.
NUV has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 37.78
ROIC/WACCN/A
WACCN/A
NUV Yearly LT Debt VS Equity VS FCFNUV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 5.22 indicates that NUV has no problem at all paying its short term obligations.
A Quick Ratio of 5.22 indicates that NUV has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 5.22
Quick Ratio 5.22
NUV Yearly Current Assets VS Current LiabilitesNUV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 117.62% over the past year.
Measured over the past years, NUV shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.98% on average per year.
NUV shows a small growth in Revenue. In the last year, the Revenue has grown by 4.83%.
The Revenue has been decreasing by -1.74% on average over the past years.
EPS 1Y (TTM)117.62%
EPS 3Y-3%
EPS 5Y-6.98%
EPS Q2Q%15.38%
Revenue 1Y (TTM)4.83%
Revenue growth 3Y-2.04%
Revenue growth 5Y-1.74%
Sales Q2Q%5.21%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NUV Yearly Revenue VS EstimatesNUV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 32.11, NUV can be considered very expensive at the moment.
When comparing the Price/Earnings ratio of NUV to the average of the S&P500 Index (28.78), we can say NUV is valued inline with the index average.
Industry RankSector Rank
PE 32.11
Fwd PE N/A
NUV Price Earnings VS Forward Price EarningsNUV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NUV Per share dataNUV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

NUV has a Yearly Dividend Yield of 3.95%.
NUV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.46.
Industry RankSector Rank
Dividend Yield 3.95%

5.2 History

NUV has paid a dividend for at least 10 years, which is a reliable track record.
NUV has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
NUV Yearly Dividends per shareNUV Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
NUV Yearly Income VS Free CF VS DividendNUV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M -300M

More info and screens

NUVEEN MUNICIPAL VALUE

NYSE:NUV (4/25/2025, 8:04:00 PM)

8.67

-0.01 (-0.12%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)01-06 2025-01-06
Earnings (Next)06-30 2025-06-30
Inst Owners26.96%
Inst Owner Change0.8%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.80B
Analysts45
Price TargetN/A
Short Float %0.13%
Short Ratio0.54
Dividend
Industry RankSector Rank
Dividend Yield 3.95%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date04-15 2025-04-15 (0.0325)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 32.11
Fwd PE N/A
P/S 21.88
P/FCF N/A
P/OCF N/A
P/B 1
P/tB 1
EV/EBITDA N/A
EPS(TTM)0.27
EY3.11%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.4
BVpS8.69
TBVpS8.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3%
ROE 3.04%
ROCE 3.95%
ROIC 3.12%
ROICexc 3.14%
ROICexgc 3.14%
OM 87.61%
PM (TTM) 66.8%
GM 98.86%
FCFM N/A
ROA(3y)-3.15%
ROA(5y)-0.67%
ROE(3y)-3.2%
ROE(5y)-0.67%
ROIC(3y)2.88%
ROIC(5y)2.83%
ROICexc(3y)2.88%
ROICexc(5y)2.83%
ROICexgc(3y)2.89%
ROICexgc(5y)2.83%
ROCE(3y)3.64%
ROCE(5y)3.58%
ROICexcg growth 3Y4.55%
ROICexcg growth 5Y1.06%
ROICexc growth 3Y4.55%
ROICexc growth 5Y1.06%
OM growth 3Y0.06%
OM growth 5Y0.04%
PM growth 3Y-0.35%
PM growth 5Y-5.23%
GM growth 3Y-0.16%
GM growth 5Y-0.02%
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.22
Quick Ratio 5.22
Altman-Z 37.78
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.62%
EPS 3Y-3%
EPS 5Y-6.98%
EPS Q2Q%15.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.83%
Revenue growth 3Y-2.04%
Revenue growth 5Y-1.74%
Sales Q2Q%5.21%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.29%
EBIT growth 3Y-1.98%
EBIT growth 5Y-1.71%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A